Subrata Deb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Subrata Deb has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- A. H. M. Imrul Tareq
Army Medical College and Combined Military Hospital, Chattogram 4210, Bangladesh
1 shared publication - Agus Rizal Ardy Hariandy Hamid
Department of Urology Jakarta Cipto Mangunkusumo Hospital / Faculty of Medicine, Universitas Indonesia
1 shared publication - Isaac A. Thangasamy
Nepean Urology Research Group, Nepean Hospital, Kingswood, NSW 2747, Australia
1 shared publication - Jeremy Yuen-Chun Teoh
Department of Surgery, S.H. Ho Urology Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong
1 shared publication - Mohammad Shoaib
Department of Urology, Peshawar Medical College, Peshawar, Pakistan
1 shared publication - Muhammad Zohair
Department of Urology, Institute of Kidney Diseases Hayatabad, Peshawar 25100, Pakistan
1 shared publication
Latest Publications
- Open Access
- 12 August 2025
- Published by MDPI AG in Société Internationale d’Urologie Journal
- Vol. 6 (4) , 53
Artificial Intelligence in Urology—A Survey of Urology Healthcare Providers
Background/Objectives: Artificial intelligence (AI) has been utilised in urological conditions such as urolithiasis, urogynaecology and uro-oncology. The aim of this study is to examine the attitudes and beliefs about AI technology amongst urology healthcare providers. Methods: A structured online questionnaire, created from a modified Delphi method with a panel of urologists and urology surgical trainees, was delivered through the Urological Asia Association’s annual congress. The questionnaire, with 25 items of mixed type responses (five-point Likert scale, nominal-polytomous and open-ended), acquired data regarding demographics, perception and attitudes towards general usage of AI in urological care. Results: A total of 464 respondents from 47 different countries were collected. The results showed that 83.4% of participants believed AI will improve efficiency and 18.8% believed they are knowledgeable in AI technology, with ordinal logistic regression showing both urology specialists and trainees are more likely to agree to these responses. Overall, 51.5% believed AI adoption will not replace clinical practice, and regression analysis found those with previous AI training are more likely to agree to this response. We found AI is commonly used in research, patient education and administrative tasks and identified key enablers as regulatory approval, AI clinical effectiveness and access to AI training. Conclusions: Overall attitudes and beliefs towards the use of AI in urology is positive and encouraging. AI training and education and regulatory reform needs to be addressed to allow integration of AI into clinical practice. A limitation of the study lies in its generalisability to global settings due to the demographics of the respondents.
- 12 August 2025
- Published by MDPI AG in Société Internationale d’Urologie Journal
- Vol. 6 (4) , 53
Open AccessArtificial Intelligence in Urology—A Survey of Urology Healthcare Providers
Background/Objectives: Artificial intelligence (AI) has been utilised in urological conditions such as urolithiasis, urogynaecology and uro-oncology. The aim of this study is to examine the attitudes and beliefs about AI technology amongst urology healthcare providers. Methods: A structured online questionnaire, created from a modified Delphi method with a panel of urologists and urology surgical trainees, was delivered through the Urological Asia Association’s annual congress. The questionnaire, with 25 items of mixed type responses (five-point Likert scale, nominal-polytomous and open-ended), acquired data regarding demographics, perception and attitudes towards general usage of AI in urological care. Results: A total of 464 respondents from 47 different countries were collected. The results showed that 83.4% of participants believed AI will improve efficiency and 18.8% believed they are knowledgeable in AI technology, with ordinal logistic regression showing both urology specialists and trainees are more likely to agree to these responses. Overall, 51.5% believed AI adoption will not replace clinical practice, and regression analysis found those with previous AI training are more likely to agree to this response. We found AI is commonly used in research, patient education and administrative tasks and identified key enablers as regulatory approval, AI clinical effectiveness and access to AI training. Conclusions: Overall attitudes and beliefs towards the use of AI in urology is positive and encouraging. AI training and education and regulatory reform needs to be addressed to allow integration of AI into clinical practice. A limitation of the study lies in its generalisability to global settings due to the demographics of the respondents.